BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function.
- DOI
- 10.1016/j.clml.2026.04.022
- Published
- 2026 Jul
- Container
- Clinical lymphoma, myeloma & leukemia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clml.2026.04.022,
title = {BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function.},
author = {Pour L and Delimpasi S and Legiec W and Minarik J and Spicka I and Grosicki S and Rymko M and Najda J and Symeonidis A and Andersson B and Huledal G and Norin S and Dimopoulos MA},
year = {2026},
journal = {Clinical lymphoma, myeloma \& leukemia},
doi = {10.1016/j.clml.2026.04.022},
url = {https://doi.org/10.1016/j.clml.2026.04.022}
}RIS
TY - JOUR TI - BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function. AU - Pour L AU - Delimpasi S AU - Legiec W AU - Minarik J AU - Spicka I AU - Grosicki S AU - Rymko M AU - Najda J AU - Symeonidis A AU - Andersson B AU - Huledal G AU - Norin S AU - Dimopoulos MA PY - 2026 JO - Clinical lymphoma, myeloma & leukemia DO - 10.1016/j.clml.2026.04.022 UR - https://doi.org/10.1016/j.clml.2026.04.022 ER -
APA
L, P., S, D., W, L., J, M., I, S., S, G., M, R., J, N., A, S., B, A., G, H., S, N., & MA, D. (2026). BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function.. Clinical lymphoma, myeloma & leukemia. https://doi.org/10.1016/j.clml.2026.04.022
Source records
- pubmed · retrieved 2026-09-27T06:54:18.040Z